Marksans Pharma Limited - Company Profile

Q: Who are the current directors of Marksans Pharma Limited?

The current directors of Marksans Pharma Limited are Varddhman Vikramaditya Jain, Abhinna Mohanty Sundar, Seetharama Raju Buddharaju, Sunny Sharma, Shailaja Vardhan, Jitendra Mahabirprasad Sharma, Sandra Saldanha, Harshavardhan Panigrahi, Jitendra Mahabir Prasad Sharma, Mark Saldanha, Digant Mahesh Parikh, Srinivas Mishra, Jitendra Mahabirprasad Sharma.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1992.

1992 Mumbai, Maharashtra, India Active

Last Updated: December 23, 2025

Access Report

About Marksans Pharma Limited

Marksans Pharma Limited, a active public limited company, was established on 16 April 1992 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24110MH1992PLC066364. Registered under ROC Roc Mumbai. it is listed on BSE: 524404 and NSE: MARKSANS. It has an authorized capital of ₹69.00 Cr and a paid-up capital of ₹45.32 Cr.

Formerly known as Tasc Pharmaceuticals Limited, Tasc Industries (India) Limited. It upholds a compliant status. In 2023, it reported revenue of ₹715.69 Cr and a net worth of ₹1,111.32 Cr. Employing 95 professional, Its leadership includes Varddhman Vikramaditya Jain (Whole-Time Director), Abhinna Mohanty Sundar (Director), Seetharama Raju Buddharaju (Director). Past directors included Vinay Gopal Nayak, Kim Tan Sze, Varddhman Vikramaditya Jain. It holds ₹226.00 Cr open charges and ₹337.16 Cr settled loans. Its latest AGM occurred on 08 August 2025, with the balance sheet filed on 31 March 2025. It is based at 11Th Floor, Grandeur, Veera Desai Extension Road Oshiwara, Andheri (W), Mumbai, Maharashtra, 400053.

Company Details

CIN/LLPIN
L24110MH1992PLC066364
Registration Number
066364
Incorporation Date
16 April 1992
Authorized Capital
₹69.00 Cr
Paid-Up Capital
₹45.32 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 524404, NSE: MARKSANS)
Company Status
Active

Key Metrics

Authorised Capital ₹ 69.00 Cr as on 23-12-2025
Paid Up Capital ₹ 45.32 Cr as on 23-12-2025
Company Age 33 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 226.00 Cr as on 23-12-2025
Satisfied Charges ₹ 337.16 Cr as on 23-12-2025
Revenue Growth **** 2.16% (FY 2023)
Profit Growth **** -1.08% (FY 2023)
Ebitda **** -19.18% (FY 2023)
Net Worth 41.63% (FY 2023)
Total Assets **** 39.28% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Marksans Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Marksans Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Varddhman Vikramaditya Jain	Whole-Time Director	24 Jan 2019	Current
Abhinna Mohanty Sundar	Director	11 Jul 2019	Current
Seetharama Raju Buddharaju	Director	05 Oct 2011	Current
Sunny Sharma	Director	11 Aug 2021	Current
Shailaja Vardhan	Director	30 May 2023	Current
Jitendra Mahabirprasad Sharma	Deputy Nodal Officer	22 Aug 2024	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	29 Sep 2016	Past
Pramod Abcsdd	Director	25 Sep 2009	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	29 Sep 2020	Past
Pramod Abcsdd	Additional Director	23 Sep 2021	Past
Pramod Abcsdd	Additional Director	26 Sep 2019	Past
Pramod Abcsdd	Director Appointed In Casual Vacancy	26 Sep 2013	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Marksans Pharma.

Marksans Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.16% increase. The company also saw a slight decrease in profitability, with a 1.08% decrease in profit. The company's net worth Soared by an impressive increase of 41.63%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

2.16%

*******

Revenue from Operations

*******

-0.47%

*******

Total Assets

*******

39.28%

*******

Profit or Loss

*******

-1.08%

*******

Net Worth

*******

41.63%

*******

EBITDA

*******

-19.18%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Marksans Pharma?

In 2023, Marksans Pharma had a promoter holding of 43.85% and a public holding of 56.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,260,000,000.00

Satisfied Charges

₹3,371,598,900.00

Charges Breakdown by Lending Institutions

State Bank Of India : 226.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
07 Feb 2006	State Bank Of India	₹226.00 Cr	Open
07 Sep 2017	State Bank Of India	₹66.80 Cr	Satisfied
23 Jun 2015	State Bank Of India	₹44.41 Cr	Satisfied
23 Dec 2013	Bank Of India	₹4.00 Cr	Satisfied
13 Aug 2010	Bank Of India	₹6.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Marksans Pharma?

Marksans Pharma has a workforce of 95 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Marksans Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marksans Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Marksans Pharma

Recent Activity within the Organization

Annual General Meeting

Marksans Pharma Limited last Annual general meeting of members was held on 08 Aug 2025 as per latest MCA records. was recorded as a recent event.
08 Aug 2025
Director Appointment

Progress on Srinivas Mishra was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 10 months 9 days . was documented.
01 Apr 2025
Balance Sheet

The activity Marksans Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
31 Mar 2025
Charges

A charge with State Bank Of India of Rs. 226.00 Cr registered on 07 Feb 2006 with Charge ID 80034914 was modified on 03 Feb 2025. was recorded as a recent event.
03 Feb 2025
Director Appointment

Jitendra Mahabirprasad Sharma was appointed as a Deputy Nodal Officer was appointed as a Deputy Nodal Officer on 22 Aug 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
22 Aug 2024
Director Appointment

Progress on Shailaja Vardhan was appointed as a Director was appointed as a Director on 30 May 2023 & has been associated with this company since 2 years 8 months . was documented.
30 May 2023

Explore recent activity and updates - View Recent Activity